Home / Share Price Target / Vistaph
Vista Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Vista Pharmaceuticals Limited | |||
 | Symbol: VISTAPH | ||
| Price: ₹12.53 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Vista Pharmaceuticals Financial Performance
- 0.1.1: Is Vista Pharmaceuticals A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vista Pharmaceuticals Share Price Target For 2024
- 1.1.1: Vista Pharmaceuticals Share Price Target Table For 2024
- 1.1.2: Summary: Vista Pharmaceuticals Share Price Prediction For 2024
- 1.2: Vista Pharmaceuticals Share Price Target For 2025
- 1.2.1: Vista Pharmaceuticals Share Price Target Table For 2025
- 1.2.2: Summary: Vista Pharmaceuticals Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vista Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Vista Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Vista Pharmaceuticals Past Performance
Vista Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 44.5 Crore | Market valuation of Vista Pharmaceuticals's shares. |
| Revenue (TTM) | 1 Crore | Total revenue generated by Vista Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | -5.66 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -454.96% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -218.25% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -50.88% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 0.23 | Company's total debt divided by total shareholder equity. |
| Total Debt | 9.25 Crore | Sum of Vista Pharmaceuticals's current & long-term financial obligations. |
Is Vista Pharmaceuticals A Good Buy For Long Term?
Vista Pharmaceuticals, a small-cap stock with weak financial performance, may not be a suitable long-term investment at this time. Its recent revenue decline, negative profit margin, and high debt raise concerns about its financial stability. While the stock has shown some positive returns in the past year, its long-term performance has been negative, indicating potential risks for investors.
To predict the Vista Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vista Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Vista Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vista Pharmaceuticals shares in 2024, see the table below.
Vista Pharmaceuticals Share Price Target Table For 2024
| Vista Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 13.00 (+3.75%) | Price Action: Jun 2007 Low |
| 2024 Target 2 | 12.84 (+2.47%) | Price Action: 17 Oct 2024 High |
| 2024 Target 1 | 12.65 (+0.95%) | Price Action: Jun 2024 Low |
| Current Price | 12.53 | Vista Pharmaceuticals's 1 share price as of Fri 08 Nov 2024 |
| Stop Loss 1 | 12.46 (-0.56%) | Price Action: 28 Oct 2024 High |
| Stop Loss 2 | 12.31 (-1.76%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 3 | 12.18 (-2.8%) | Price Action: May 2005 High |
Summary: Vista Pharmaceuticals Share Price Prediction For 2024
In summary, Vista Pharmaceuticals has declined by ₹-2.14, recording a notable -14.59% decrease from 1st January 2024 to 08 Nov 2024. Despite the setback, our analysis of Vista Pharmaceuticals for 2024 predicts an additional rise of 0.95% to 3.75% by the end of 2024 with three potential targets T1: 12.65, T2: 12.84, T3: 13.00. Stop Loss at SL1: 12.46, SL2: 12.31, SL3: 12.18.
Vista Pharmaceuticals has a 52-week high of ₹19.32, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹10.43, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Vista Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vista Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Vista Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vista Pharmaceuticals shares in 2025, see the table below.
Vista Pharmaceuticals Share Price Target Table For 2025
| Vista Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 18.83 (+50.27%) | Price Action: Chart |
| 2025 Target 2 | 18.48 (+47.48%) | Price Action: Chart |
| 2025 Target 1 | 18.30 (+46.04%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 12.53 | Vista Pharmaceuticals's 1 share price as of Fri 08 Nov 2024 |
| Stop Loss 1 | 11.20 (-10.62%) | Price Action: Sep 2011 High |
| Stop Loss 2 | 11.00 (-12.22%) | Price Action: Feb 2011 Low |
| Stop Loss 3 | 10.84 (-13.49%) | Price Action: Jan 2022 Low |
Summary: Vista Pharmaceuticals Share Price Prediction For 2025
In summary, Vista Pharmaceuticals has declined by ₹-2.14, recording a notable -14.59% decrease from 1st January 2024 to 08 Nov 2024. Despite the setback, our analysis of Vista Pharmaceuticals for 2025 predicts an additional rise of 46.04% to 50.27% by the end of 2025 with three potential targets T1: 18.30, T2: 18.48, T3: 18.83. Stop Loss at SL1: 11.20, SL2: 11.00, SL3: 10.84.
Vista Pharmaceuticals has a All-Time high of ₹56.15, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹10.43, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Vista Pharmaceuticals, we have created a specific page for that check here: Vista Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vista Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Vista Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.88% over the next 15 years.
For complete year by year Vista Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Vista Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Vista Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹12.53 | [Current Price] |
| 2024 | ₹12.67 | 1.11% |
| 2025 | ₹13.2 | 4.18% |
| 2026 | ₹13.8 | 4.54% |
| 2027 | ₹14.54 | 5.36% |
| 2028 | ₹15.52 | 6.74% |
| 2029 | ₹13.96 | -10.06% |
| 2030 | ₹14.52 | 4.01% |
| 2031 | ₹15.15 | 4.33% |
| 2032 | ₹15.94 | 5.21% |
| 2033 | ₹16.98 | 6.52% |
| 2034 | ₹15.25 | -10.19% |
| 2035 | ₹15.84 | 3.86% |
| 2036 | ₹16.5 | 4.16% |
| 2037 | ₹17.32 | 5.03% |
| 2038 | ₹18.44 | 6.4% |
| 2039 | ₹16.44 | -10.85% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vista Pharmaceuticals Past Performance
- In 2002, Vista Pharmaceuticals opening price was ₹0.45
- As of Fri 08 Nov 2024 the price stands at ₹12.53.
- This represents a Compound Annual Growth Rate (CAGR) of 15.56%.
- In 22 years, an investment of 10,000 would have become ₹2.78 Lakh.
As we wrap up, we hope you like our study on Vista Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
